Terms: = Breast cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Prognosis
10 results:
1. Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer.
Haq ATA; Yang PP; Jin C; Shih JH; Chen LM; Tseng HY; Chen YA; Weng YS; Wang LH; Snyder MP; Hsu HL
Theranostics; 2024; 14(5):2167-2189. PubMed ID: 38505617
[No Abstract] [Full Text] [Related]
2. Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment.
Chen X; Hu G; Yu Q
Front Endocrinol (Lausanne); 2023; 14():1256132. PubMed ID: 38116315
[TBL] [Abstract] [Full Text] [Related]
3. Construction of a prognostic model for triple-negative breast cancer based on immune-related genes, and associations between the tumor immune microenvironment and immunological therapy.
Zhu Y; Tao LF; Liu JY; Wang YX; Huang H; Jiang YN; Qian WF
Cancer Med; 2023 Jul; 12(14):15704-15719. PubMed ID: 37306188
[TBL] [Abstract] [Full Text] [Related]
4. Bioinformatics Analysis Identifies il6st as a Potential Tumor Suppressor Gene for Triple-Negative breast cancer.
Jia R; Weng Y; Li Z; Liang W; Ji Y; Liang Y; Ning P
Reprod Sci; 2021 Aug; 28(8):2331-2341. PubMed ID: 33650093
[TBL] [Abstract] [Full Text] [Related]
5. IL-6 and Soluble Receptors in Overweight and Obese African American Women With and Without breast cancer.
Griffith KA; Ryan AS
Biol Res Nurs; 2021 Apr; 23(2):218-222. PubMed ID: 32748635
[TBL] [Abstract] [Full Text] [Related]
6. Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict's value.
Chow LWC; Morita S; Chow CYC; Ng WK; Toi M
Endocr Relat Cancer; 2018 Feb; 25(2):123-130. PubMed ID: 29158285
[TBL] [Abstract] [Full Text] [Related]
7. Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer.
Heo TH; Wahler J; Suh N
Oncotarget; 2016 Mar; 7(13):15460-73. PubMed ID: 26840088
[TBL] [Abstract] [Full Text] [Related]
8. Gender-associated expression of tumor markers and a small gene set in breast carcinoma.
Andres SA; Smolenkova IA; Wittliff JL
Breast; 2014 Jun; 23(3):226-33. PubMed ID: 24656773
[TBL] [Abstract] [Full Text] [Related]
9. [Interleukin-6 and its soluble receptors in human breast cancer].
Kuang Y; Zhang Z; Zhang X
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):305-7. PubMed ID: 10920992
[TBL] [Abstract] [Full Text] [Related]
10. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.
Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A
Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718
[TBL] [Abstract] [Full Text] [Related]
